Beyond the Bit: Quantum Pathways
In this episode, I am joined by Matthias Kaiser — Founder of PexMachina — who returns to the podcast fresh off securing investment from Wavepeak Ventures, Eric Hall’s new quantum applications fund. Since our first conversation, Matthias has founded Pex Machina, a quantum applications company focused on pharmaceutical drug development, using quantum simulation to model molecular interactions more precisely. This episode explores the reality of building in quantum today — from finding meaningful applications and validating customer workflows, to fundraising, IP, AI-assisted software development, and hiring in deep tech. We discuss: 🧠 Why quantum needs real applications, not just technical promise 💊 How Pex Machina is applying quantum simulation to pharmaceutical drug discovery 🧬 Why oncology, therapeutic windows, and molecular interactions are such important use cases 🔬 The role of wet lab validation in making simulation useful for pharma 💸 Bootstrapping, accelerator funding, and securing early VC investment 🚀 Why Eric Hall’s investment through Wavepeak matters for quantum applications ⚖️ Why IP strategy matters early in pharma and biotech 🤖 How AI is changing software development and early hiring strategy 👥 Building the right founding team, advisory board, and company culture 🌍 Why customer workflows matter as much as the quantum algorithm Guest: Matthias Kaiser Founder, PexMachina.com
23 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Beyond the Bit: Quantum Pathways!